Authors: Pierre-Yves Lozach (Heidelberg University; Germany)
In this ‘Peek Behind the Paper’ feature, we take a look behind the scenes of a recent Perspective from the journal Future Virology, titled ‘Rift Valley fever virus: a new avenue of research on the biological functions of amyloids?‘
Here, Atiya Henry, the Commissioning Editor for Future Virology at Future Science Group (London, UK), asks corresponding author of the study Pierre-Yves Lozachto (Heidelberg University; Germany) about Rift Valley fever virus (RVFV), a mosquito-borne viral zoonosis that primarily infects domestic animals and humans.
What inspired you to write this piece?
The elegant simplicity of RVFV has always fascinated me, so basic but so frighteningly effective. Although identified by WHO as a pathogen for which there is an urgent need to develop diagnostics, therapies and research, RVFV remains globally poorly characterized. The virus left Africa a few decades ago and represents a risk of introduction into southern Europe and Asia. I was motivated by the idea of introducing RVFV and its impressive NSs protein to a wider audience than specialists, which I hope will go beyond virologists.
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Infectious Diseases Hub or Future Science Group.